The Auckland-based drugmaker, AFT Pharmaceuticals, is partnering with a Swiss-based pharmaceutical company to licence its painkiller, Maxigesic, for sale in a further 69 countries.
Recent stories from Business News
Get the RNZ app
for easy access to all your favourite programmes
